These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23706692)

  • 21. Recommendations for the treatment of localized prostate cancer by permanent interstitial brachytherapy.
    Hakenberg OW; Wirth MP; Hermann T; Alken P; Kovacs G; Müller RP; Ahlemann L; Schalkhäuser K
    Urol Int; 2003; 70(1):15-20. PubMed ID: 12566809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings of the Wellcome Foundation--British Association of Surgical Oncology. Symposium on Cancer Chemotherapy: New Potential for Established Drugs? London, England, 22-23 February, 1979.
    Cancer Treat Rev; 1979 Jun; 6 Suppl():1-150. PubMed ID: 40696
    [No Abstract]   [Full Text] [Related]  

  • 23. German Cancer Society--12th International AEK Cancer Congress. 25-28 March 2003, Würzburg, Germany.
    Wetzker R
    IDrugs; 2003 May; 6(5):446-8. PubMed ID: 12841208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer link to vasectomy is weak.
    Contracept Technol Update; 1998 Mar; 19(3):31. PubMed ID: 12293271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of methadone for support of oncological treatment? : Statement of the working group on tumor pain of the German Pain Society].
    Hofbauer H; Schenk M; Kieselbach K; Wirz S
    Schmerz; 2017 Feb; 31(1):2-4. PubMed ID: 28044195
    [No Abstract]   [Full Text] [Related]  

  • 26. Optimizing the delivery of cancer drugs that block angiogenesis.
    Cao Y; Langer R
    Sci Transl Med; 2010 Jan; 2(15):15ps3. PubMed ID: 20371469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dynamic de-escalating dosing strategy to determine the optimal biological dose for antiangiogenic drugs.
    Emmenegger U; Kerbel RS
    Clin Cancer Res; 2005 Nov; 11(21):7589-92. PubMed ID: 16278375
    [No Abstract]   [Full Text] [Related]  

  • 28. Policy statement--recommended childhood and adolescent immunization schedules--United States, 2011.
    ;
    Pediatrics; 2011 Feb; 127(2):387-8. PubMed ID: 21285334
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostate cancer screening.
    Med Lett Drugs Ther; 2008 Nov; 50(1298):85-6. PubMed ID: 18978703
    [No Abstract]   [Full Text] [Related]  

  • 30. The challenges of oral agents as antineoplastic treatments.
    Given BA; Spoelstra SL; Grant M
    Semin Oncol Nurs; 2011 May; 27(2):93-103. PubMed ID: 21514479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal cell carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Escudier B; Kataja V;
    Ann Oncol; 2009 May; 20 Suppl 4():81-2. PubMed ID: 19454473
    [No Abstract]   [Full Text] [Related]  

  • 32. The possible role of chemotherapy in antiangiogenic drug resistance.
    Bocci G; Loupakis F
    Med Hypotheses; 2012 May; 78(5):646-8. PubMed ID: 22365648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Continuing medical education in systemic treatment : Are the contents adequately conveyed?].
    Gschwend JE
    Urologe A; 2010 Aug; 49(8):925-9. PubMed ID: 20652677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Policy implications of oral agents.
    Spoelstra SL; Given BA; Given CW; Grant M
    Semin Oncol Nurs; 2011 May; 27(2):161-5. PubMed ID: 21514485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Position statement of the Hungarian Radiotherapy and Oncology College on the insurance coverage of Vectibix (panitumumab)].
    Pikó B;
    Magy Onkol; 2009 Jun; 53(2):175-6. PubMed ID: 19581184
    [No Abstract]   [Full Text] [Related]  

  • 36. [Congress of the American Society of Clinical Oncology].
    André T
    J Chir (Paris); 2002 Oct; 139(5):300-3. PubMed ID: 12410132
    [No Abstract]   [Full Text] [Related]  

  • 37. American Osteopathic Association's policy statement on end-of-life care.
    End-of-Life Care Committee
    J Am Osteopath Assoc; 2005 Nov; 105(11 Suppl 5):S32-4. PubMed ID: 16368906
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal Association Clinical Practice Guideline on planning, initiating and withdrawal of renal replacement therapy.
    Farrington K; Warwick G
    Nephron Clin Pract; 2011; 118 Suppl 1():c189-208. PubMed ID: 21555896
    [No Abstract]   [Full Text] [Related]  

  • 39. Fertility preservation during treatment is a growing issue for women.
    Rowan K
    J Natl Cancer Inst; 2010 Mar; 102(5):294-6. PubMed ID: 20173119
    [No Abstract]   [Full Text] [Related]  

  • 40. [A survey of compliance to oral anti-cancer drugs in outpatients].
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):485-8. PubMed ID: 22616127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.